Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. / Vogel, Asmus; Elberling, Tina V; Hørding, Merete; Dock, Jytte; Rasmussen, Ase K; Feldt-Rasmussen, Ulla; Perrild, Hans; Waldemar, Gunhild.

In: Psychoneuroendocrinology, Vol. 32, No. 1, 2007, p. 36-43.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Vogel, A, Elberling, TV, Hørding, M, Dock, J, Rasmussen, AK, Feldt-Rasmussen, U, Perrild, H & Waldemar, G 2007, 'Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis', Psychoneuroendocrinology, vol. 32, no. 1, pp. 36-43. https://doi.org/10.1016/j.psyneuen.2006.09.012

APA

Vogel, A., Elberling, T. V., Hørding, M., Dock, J., Rasmussen, A. K., Feldt-Rasmussen, U., ... Waldemar, G. (2007). Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology, 32(1), 36-43. https://doi.org/10.1016/j.psyneuen.2006.09.012

Vancouver

Vogel A, Elberling TV, Hørding M, Dock J, Rasmussen AK, Feldt-Rasmussen U et al. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology. 2007;32(1):36-43. https://doi.org/10.1016/j.psyneuen.2006.09.012

Author

Vogel, Asmus ; Elberling, Tina V ; Hørding, Merete ; Dock, Jytte ; Rasmussen, Ase K ; Feldt-Rasmussen, Ulla ; Perrild, Hans ; Waldemar, Gunhild. / Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. In: Psychoneuroendocrinology. 2007 ; Vol. 32, No. 1. pp. 36-43.

Bibtex

@article{5435a1dc4dd045f2b2c53e311f4555ce,
title = "Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis",
abstract = "In the acute phase of Graves' thyrotoxicosis patients often have subjective cognitive complaints. Continuing controversy exists about the nature of these symptoms and whether they persist after treatment. This prospective study included 31 consecutively referred, newly diagnosed, and untreated patients with Graves' thyrotoxicosis. A control group of 34 individuals matched for age, education and premorbid intelligence was also included. At baseline all patients and control subjects were examined with psychiatric rating scales and a comprehensive neuropsychological battery. The effect of treatment on affective symptomatology was examined in the patient group after reaching euthyroidism and 1 year after treatment initiation. At initial examination patients had significantly higher scores on psychiatric rating scales as compared with controls, and the majority reported memory and concentration problems. No significant differences between the patient and the control group on neuropsychological test performances were found. Thyroid levels did not correlate with the neuropsychological test performances or psychiatric ratings. After reaching euthyroidism the level of affective symptoms (including reports of cognitive deficits) had decreased significantly, with further normalisation 1-year after treatment initiation. In conclusion, patients had subjective reports of cognitive deficits in the toxic phase of Graves' thyrotoxicosis but comprehensive neuropsychological testing revealed no cognitive impairment. Reports of cognitive dysfunction may reflect affective and somatic manifestations of thyrotoxicosis and in most patients these symptoms disappear after treatment of Graves' thyrotoxicosis.",
author = "Asmus Vogel and Elberling, {Tina V} and Merete H{\o}rding and Jytte Dock and Rasmussen, {Ase K} and Ulla Feldt-Rasmussen and Hans Perrild and Gunhild Waldemar",
year = "2007",
doi = "http://dx.doi.org/10.1016/j.psyneuen.2006.09.012",
language = "English",
volume = "32",
pages = "36--43",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Pergamon Press",
number = "1",

}

RIS

TY - JOUR

T1 - Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis

AU - Vogel, Asmus

AU - Elberling, Tina V

AU - Hørding, Merete

AU - Dock, Jytte

AU - Rasmussen, Ase K

AU - Feldt-Rasmussen, Ulla

AU - Perrild, Hans

AU - Waldemar, Gunhild

PY - 2007

Y1 - 2007

N2 - In the acute phase of Graves' thyrotoxicosis patients often have subjective cognitive complaints. Continuing controversy exists about the nature of these symptoms and whether they persist after treatment. This prospective study included 31 consecutively referred, newly diagnosed, and untreated patients with Graves' thyrotoxicosis. A control group of 34 individuals matched for age, education and premorbid intelligence was also included. At baseline all patients and control subjects were examined with psychiatric rating scales and a comprehensive neuropsychological battery. The effect of treatment on affective symptomatology was examined in the patient group after reaching euthyroidism and 1 year after treatment initiation. At initial examination patients had significantly higher scores on psychiatric rating scales as compared with controls, and the majority reported memory and concentration problems. No significant differences between the patient and the control group on neuropsychological test performances were found. Thyroid levels did not correlate with the neuropsychological test performances or psychiatric ratings. After reaching euthyroidism the level of affective symptoms (including reports of cognitive deficits) had decreased significantly, with further normalisation 1-year after treatment initiation. In conclusion, patients had subjective reports of cognitive deficits in the toxic phase of Graves' thyrotoxicosis but comprehensive neuropsychological testing revealed no cognitive impairment. Reports of cognitive dysfunction may reflect affective and somatic manifestations of thyrotoxicosis and in most patients these symptoms disappear after treatment of Graves' thyrotoxicosis.

AB - In the acute phase of Graves' thyrotoxicosis patients often have subjective cognitive complaints. Continuing controversy exists about the nature of these symptoms and whether they persist after treatment. This prospective study included 31 consecutively referred, newly diagnosed, and untreated patients with Graves' thyrotoxicosis. A control group of 34 individuals matched for age, education and premorbid intelligence was also included. At baseline all patients and control subjects were examined with psychiatric rating scales and a comprehensive neuropsychological battery. The effect of treatment on affective symptomatology was examined in the patient group after reaching euthyroidism and 1 year after treatment initiation. At initial examination patients had significantly higher scores on psychiatric rating scales as compared with controls, and the majority reported memory and concentration problems. No significant differences between the patient and the control group on neuropsychological test performances were found. Thyroid levels did not correlate with the neuropsychological test performances or psychiatric ratings. After reaching euthyroidism the level of affective symptoms (including reports of cognitive deficits) had decreased significantly, with further normalisation 1-year after treatment initiation. In conclusion, patients had subjective reports of cognitive deficits in the toxic phase of Graves' thyrotoxicosis but comprehensive neuropsychological testing revealed no cognitive impairment. Reports of cognitive dysfunction may reflect affective and somatic manifestations of thyrotoxicosis and in most patients these symptoms disappear after treatment of Graves' thyrotoxicosis.

U2 - http://dx.doi.org/10.1016/j.psyneuen.2006.09.012

DO - http://dx.doi.org/10.1016/j.psyneuen.2006.09.012

M3 - Journal article

VL - 32

SP - 36

EP - 43

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 1

ER -

ID: 48446227